Zager P G, Spalding C T, Frey H J, Brittenham M C, Nevarez M
University of New Mexico School of Medicine, Albuquerque 87131.
J Clin Endocrinol Metab. 1988 Jul;67(1):110-5. doi: 10.1210/jcem-67-1-110.
We postulated that significant quantities of both protein-bound and unbound adrenocorticoids are lost during continuous ambulatory peritoneal dialysis (CAPD). To test this hypothesis we measured the dialysate removal rates (DRR) of adrenocorticoids in six CAPD patients. The distribution of the adrenocorticoids among unbound, albumin-bound, and transcortin-bound fractions in dialysate effluent was determined. The distribution of cortisol among unbound, albumin-bound, and transcortin-bound fractions in plasma was determined in six other CAPD patients. The mean DRR of cortisol was 193.8 +/- 20.3 (+/- SE) nmol/day. Smaller quantities of 11-deoxycorticosterone, corticosterone, aldosterone, 18-hydroxy-11-deoxycorticosterone, and 18-hydroxycorticosterone were removed during CAPD. The mean DRR values for total protein, albumin, and transcortin were 11.2 +/- 2.1, 6.0 +/- 2.2, and 0.087 +/- 0.018 g/day, respectively. The distribution of cortisol among unbound, albumin-bound, and transcortin-bound fractions was normal in plasma from CAPD patients. Plasma transcortin had a normal affinity (2 x 10(7) mol/L-1) and a normal binding capacity (559 nmol/L) for cortisol. In contrast, dialysate transcortin had a low affinity (1.4 x 10(7) mol/L-1) for cortisol and a low cortisol-binding capacity (11.5 nmol/L). The fractional occupancy rates of high affinity cortisol-binding sites on transcortin were 52.0 +/- 3.3% and 3.3 +/- 0.6% in plasma and dialysate effluent, respectively (P less than 0.001). The transcortin to cortisol molar concentration ratio in dialysate (6.3 +/- 0.6) was significantly higher than that in plasma (1.6 +/- 0.2; P less than 0.001). These results demonstrate that cortisol is the major adrenocorticoid lost during CAPD. However, the amount of cortisol removed in the dialysate is less than 1% of the normal daily secretion rate. Significant quantities of other adrenocorticoids are also lost during CAPD. The adrenocorticoids present in dialysate effluent are principally unbound, in contrast to their state in plasma. However, small fractions of the respective steroids are bound to transcortin and albumin.
我们推测,在持续性非卧床腹膜透析(CAPD)过程中,大量与蛋白结合及未结合的肾上腺皮质激素会流失。为验证这一假设,我们测定了6例CAPD患者肾上腺皮质激素的透析液清除率(DRR)。确定了透析液流出液中肾上腺皮质激素在未结合、白蛋白结合及皮质素结合部分的分布情况。在另外6例CAPD患者中,测定了血浆中皮质醇在未结合、白蛋白结合及皮质素结合部分的分布情况。皮质醇的平均DRR为193.8±20.3(±SE)nmol/天。在CAPD过程中,11-脱氧皮质酮、皮质酮、醛固酮、18-羟-11-脱氧皮质酮及18-羟皮质酮的清除量较少。总蛋白、白蛋白及皮质素的平均DRR值分别为11.2±2.1、6.0±2.2及0.087±0.018 g/天。CAPD患者血浆中皮质醇在未结合、白蛋白结合及皮质素结合部分的分布正常。血浆皮质素对皮质醇具有正常亲和力(2×10⁷mol/L⁻¹)及正常结合能力(559 nmol/L)。相比之下,透析液皮质素对皮质醇的亲和力较低(1.4×10⁷mol/L⁻¹),皮质醇结合能力也较低(11.5 nmol/L)。血浆及透析液流出液中皮质素上高亲和力皮质醇结合位点的占有率分别为52.0±3.3%及3.3±0.6%(P<0.001)。透析液中皮质素与皮质醇的摩尔浓度比(6.3±0.6)显著高于血浆中的比值(1.6±0.2;P<0.001)。这些结果表明,皮质醇是CAPD过程中流失的主要肾上腺皮质激素。然而,透析液中清除的皮质醇量不到正常日分泌率的1%。在CAPD过程中,其他肾上腺皮质激素也有大量流失。与血浆中情况相反,透析液流出液中的肾上腺皮质激素主要为未结合状态。不过,各甾体类激素的一小部分与皮质素及白蛋白结合。